MORBIDITY AND MORTALITY OF KPC ASSOCIATED WITH COVID-19 HOSPITAL GENERAL RIOBAMBA PERIOD 2021

• Myner Pontón General Hospital Riobamba, Ecuadorian Institute of Social Security, Riobamba, Ecuador
• Mayra Sánchez Zonal Health Coordination, Riobamba, Ecuador
• Alexis Pontón Higher Polytechnic School of Chimborazo, Riobamba, Ecuador
• Fausto Maldonado General Hospital Riobamba, Ecuadorian Institute of Social Security, Riobamba, Ecuador

DOI: https://doi.org/10.5281/zenodo.7422416

Keywords: Covid-19, KPC, Invasive Medical Devices

Abstract

The purpose of the research was to determine the pattern of morbidity and mortality of a population defined in the Riobamba General Hospital of the Ecuadorian Institute of Social Security, for cases of Klebsiella Pneumoniae producing Carbapenemases associated with Covid-29 the period from February to August of the year. 2021. A retrospective, cross-sectional, descriptive design study was conducted. Data from 34 patients admitted and distributed in the internal medicine, critical emergency and intensive care units were analyzed. For data tabulation, the SPSS 20 statistical program was used and the analysis was performed with descriptive statistics. The average age of the patients was 58 years; 59% male and 41% female; 88% admitted to the ICU; 6% admitted to Internal Medicine; 6% admitted in Emergency Critical; 48% without underlying pathologies; 20% with essential arterial hypertension; 14% with type 2 diabetes mellitus, 9% with hypothyroidism, and 9% with other underlying pathologies such as polycythemia, renal failure, and venous insufficiency. 85% of the patients were infected and 15% colonized. 88% had pneumonia associated with mechanical ventilation; 6% had a 59 CVC-associated bloodstream infection and 6% a urinary tract infection associated with an indwelling urinary catheter. The attack rate represented 28% and the mortality rate 73%, which represents a real public health problem in cases of Klebsiella Pneumoniae producing Carbapenems associated with Covid-19 and the use of Invasive Medical Devices

References

Acosta G, Escobar G, Bernaola G, Alfaro J, Taype W, Marcos C, et al. Caracterización de pacientes con COVID-19 grave atendidos en un hospital de referencia nacional del Perú. Rev Peru Med Exp Salud Pública. 2020[acceso: 29/05/2020];37(2):253-8. Disponible en: https://rpmesp.ins.gob.pe/index.php/rpmesp/article/view/5437/3535

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y et al. Epidemiological and clinical characteristics of
99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020
[acceso: 07/05/2020];395(10223): 507-513. Disponible en: https://www.thelancet.com/journals/
lancet/article/PIIS0140-6736%2820%2930211-7/fulltext#seccestitle150

Fernández Rodríguez A, Casas I, Culebras E, Morilla E, Cohen MC, Alberola J. COVID-19 y estudios microbiológicos post mortem. Revista Española de Medicina Legal. 2020[acceso: 26/05/2020];46(3):127-38. Disponible en: https://www.sciencedirect.com/science/article/pii/S037747322030030-4/pdf?md5=e 63c25ee2a89a69b3bd95fae7f52ebbcbe&pid=1-s2.0-S0377473220300304-main.pdf

González Castro A, Escudero Acha P, Peñasco Y, Leizaola A, Martínez de Pinillos Sánchez V, García de Lorenzo A. Cuidados intensivos durante la epidemia de coronavirus 2019. Medicina Intensiva. 2020. [acceso: 27/05/2020]. Disponible en: https://www.sciencedirect.com/science/article/pii/S0210569120300899

Kim D, Quinn J, Pinsky B, Shah NH, Brown I. Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens. JAMA. 2020[acceso: 11/05/2020];323(20):2085-6. Disponible en:
http://scholar.google.com/scholar_url?url=https:// jamanetwork. com/journals/jama/articlepdf/2764787/jama_kim_2020_ld_200032.-pdf&hl=es&sa=T&oi=ucasa&ct=ufr&ei=Y9jCXqTAHPiLy9YP8KehmA-o&scisig=AAGBfm2hiKsZ6FMpE4himcrxSVDe56yXmA&nossl=1

Kirchhelle C, Roberts A, Singer AC. Antibiotic Resistance Could Lead to More COVID-19 Deaths. Scientific American. 2020[acceso: 30/05/2020];2(2):[aprox. 8 pant.] Disponible en:https://blogs.scientificamerican.com/observations/antibiotic-resistance-could-lead-to-morecovid-19-deaths/

Kluge S, Janssens U, Welte T, Weber-Carstens S, Marx G, Karagiannidis C. German recommendations for critically ill patients with COVID 19. Med Klin Intensivmed Notfmed. 2020[acceso: 26/05/2020];1-4. Disponible en: https://www.ncbi. nlm.nih.gov/pmc/articles/PMC7155395/

Liu J, Liao X, Qian S et al. Community transmission of severe acute respiratory syndrome coronavirus 2, Shenzhen, China, 2020. Emerg Infect Dis 2020 doi.org/10.3201/eid2606.200239

Ministerio de Salud Pública del Ecuador (2019).Gaceta IAAS 2018. Quito, Ecuador. Recuperadode:2019https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwjw8Ki_t7n2AhXKSjABHQVCB2IQFnoECBIQAQ&url=https%3A%2F%2Fwww.salud.gob.ec%2Fwp-content%2Fuploads%2F2019%-2F10%2FGaceta-IAAS-2018-CORRECCIONES-SNVSPv2.pdf&usg=AOvVaw-3maWO7sXuCZuVxhl8q_t9S

Monté Cerero L, Martínez Casanueva R. Microorganismos aislados en pacientes ingresados.
Hospital “Salvador Allende”, La Habana. Febrero a junio de 2015. Revista Habanera de Ciencias
Médicas. 2017[acceso: 07/05/2020];16(4):[aprox.11 p.]. Disponible en: http://www.revhabanera.sld.cu/index.php/rhab/article/view/1326

Rawson TM, Moore LSP, Zhu N, Ranganathan N, Skolimowska K, Gilchrist M, et al. Bacterial and fungal co-infection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis. 2020[acceso: 26/05/2020]; 0954162(478):1-4. Disponible en: https://academic.oup.com/cid/advance-article/ doi/10.1093/cid/ciaa530/5828058

Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated witha new coronavirus of probable bat origin. Nature. 2020 [acceso: 11/05/2020];579:270-3. Disponible en: https://doi.org/10.1038/s41586-020-2012-7